Skip to content

Equity
Compensation

Executive Compensation for Pharma, Biopharma & Med Tech Sales & Commercial Leaders

Equity compensation in life sciences is rarely simple. Between incentive stock options, RSUs, ESPPs, and nonqualified deferred compensation plans, executives in pharmaceutical, biopharma, and medical technology companies face decisions that can significantly impact their long-term wealth, and get it wrong just as easily.

Just as three generations of experience have shaped how we protect and grow our clients’ assets, that same generational expertise informs how we guide executives through the complexities of equity compensation, balancing today’s decisions against the legacy you’re building for tomorrow. Our approach includes:

Stock Option, RSU & ESPP Strategy

We help you evaluate exercise timing, tax implications, and diversification strategy so your equity compensation works toward your broader financial goals, not against them.

Deferred Compensation Planning

Nonqualified deferred comp plans carry unique risks and opportunities. We help you weigh election timing, distribution planning, and how these benefits integrate with your overall retirement and tax strategy.

Concentrated Stock Position Management

A large equity stake in your employer can mean outsized risk. We build strategies to manage concentration risk while being mindful of tax consequences, blackout periods, and insider trading considerations.

Advisory services are offered through Leone and Company Wealth Management LLC, a DBA of Forefront Advisor Network. Securities are offered through Calton & Associates, Inc., member FINRA and SIPC. Forefront Advisor Network and Leone & Company Wealth Management LLC are not owned or controlled by Calton & Associates, Inc.

Check the background of investment professionals associated with this site on FINRA’s BrokerCheck.

Forefront Wealth Partners, LLC (“FWP”) is an investment adviser registered with the U.S. Securities and Exchange Commission. All views, expressions, and opinions included in this communication are subject to change. This communication is not intended as an offer or solicitation to buy, hold or sell any financial instrument or investment advisory services. Any information provided has been obtained from sources considered reliable, but we do not guarantee the accuracy or the completeness of any description of securities, markets or developments mentioned. We may, from time to time, have a position in the securities mentioned and may execute transactions that may not be consistent with this communication’s conclusions. Please contact us at (856) 846-6898 if there is any change in your financial situation, needs, goals or objectives, or if you wish to initiate any restrictions on the management of the account or modify existing restrictions. Additionally, we recommend you compare any account reports from FWP with the account statements from your Custodian. Please notify us if you do not receive statements from your Custodian on at least a quarterly basis. Our current disclosure brochures, Form ADV Part 2 and Form ADV Part 3, are available for your review upon request, and on our website, https://forefrontwealthpartners.com. This disclosure brochure, or a summary of material changes made, is also provided to our clients on an annual basis.

LEGAL: Leone Privacy Policy | Forefront CRS | Forefront ADV Part 2A | Forefront ADV Part 2B | Forefront Privacy Policy | Calton CRS | Calton Privacy Policy | FINRA | SIPC

Registration does not imply a certain level of skill or training.

Copyright © Leone and Company Wealth Management LLC All Rights Reserved | Designed by Apis Productions